Technical Analysis for TWST - Twist Bioscience Corporation
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Stochastic Buy Signal | Bullish | -0.51% | |
| Calm After Storm | Range Contraction | -0.51% | |
| NR7 | Range Contraction | -0.51% | |
| Earnings Movers | Other | -0.51% | |
| Inside Day | Range Contraction | -0.51% | |
| Oversold Stochastic | Weakness | -0.51% | |
| 20 DMA Resistance | Bearish | -0.77% |
| Alert | Time |
|---|---|
| Possible NR7 | about 18 hours ago |
| Fell Below Previous Day's Low | about 22 hours ago |
| Down 2 % | about 22 hours ago |
| Down 1% | about 22 hours ago |
| 60 Minute Opening Range Breakdown | 2 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/18/2024
We are a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. We are leveraging our unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next generation sample (NGS) preparation, and antibody libraries for drug discovery and development. We are also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. We make products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Emerging Technologies Drug Discovery Genomics Genetic Engineering Industrial Chemical Synthetic Biology Molecular Genetics Dna Synthesis Silicon Chip
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Emerging Technologies Drug Discovery Genomics Genetic Engineering Industrial Chemical Synthetic Biology Molecular Genetics Dna Synthesis Silicon Chip
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 60.9 |
| 52 Week Low | 23.07 |
| Average Volume | 731,386 |
| 200-Day Moving Average | 42.74 |
| 50-Day Moving Average | 43.93 |
| 20-Day Moving Average | 42.37 |
| 10-Day Moving Average | 42.57 |
| Average True Range | 2.68 |
| RSI (14) | 45.95 |
| ADX | 12.81 |
| +DI | 26.92 |
| -DI | 27.01 |
| Chandelier Exit (Long, 3 ATRs) | 40.78 |
| Chandelier Exit (Short, 3 ATRs) | 44.81 |
| Upper Bollinger Bands | 47.27 |
| Lower Bollinger Band | 37.47 |
| Percent B (%b) | 0.37 |
| BandWidth | 23.12 |
| MACD Line | -0.77 |
| MACD Signal Line | -0.48 |
| MACD Histogram | -0.2926 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 43.31 | ||||
| Resistance 3 (R3) | 43.26 | 42.48 | 42.95 | ||
| Resistance 2 (R2) | 42.48 | 41.92 | 42.50 | 42.82 | |
| Resistance 1 (R1) | 41.79 | 41.57 | 42.13 | 41.84 | 42.70 |
| Pivot Point | 41.01 | 41.01 | 41.18 | 41.03 | 41.01 |
| Support 1 (S1) | 40.32 | 40.45 | 40.67 | 40.38 | 39.52 |
| Support 2 (S2) | 39.54 | 40.10 | 39.56 | 39.40 | |
| Support 3 (S3) | 38.85 | 39.54 | 39.27 | ||
| Support 4 (S4) | 38.91 |
